Engineering virus-like particles for lymph-node targeted cancer immunotherapy: strategies, challenges, and future prospects

Hitesh Harsukhbhai Chandpa, Ruchika, Shovan Naskar, Ankit Saneja, Jairam Meena

Open source

DOI
10.1016/j.drudis.2026.104647
Published
2026-05
Container
Drug Discovery Today
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.drudis.2026.104647,
  title = {Engineering virus-like particles for lymph-node targeted cancer immunotherapy: strategies, challenges, and future prospects},
  author = {Hitesh Harsukhbhai Chandpa and Ruchika and Shovan Naskar and Ankit Saneja and Jairam Meena},
  year = {2026},
  journal = {Drug Discovery Today},
  doi = {10.1016/j.drudis.2026.104647},
  url = {https://doi.org/10.1016/j.drudis.2026.104647}
}

RIS

TY  - JOUR
TI  - Engineering virus-like particles for lymph-node targeted cancer immunotherapy: strategies, challenges, and future prospects
AU  - Hitesh Harsukhbhai Chandpa
AU  - Ruchika
AU  - Shovan Naskar
AU  - Ankit Saneja
AU  - Jairam Meena
PY  - 2026
JO  - Drug Discovery Today
DO  - 10.1016/j.drudis.2026.104647
UR  - https://doi.org/10.1016/j.drudis.2026.104647
ER  - 

APA

Chandpa, H. H., Ruchika, Naskar, S., Saneja, A., & Meena, J. (2026). Engineering virus-like particles for lymph-node targeted cancer immunotherapy: strategies, challenges, and future prospects. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2026.104647

Source records